Related Experiment Video
Updated: Nov 12, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
GRP78 in lung cancer
Shengkai Xia1, Wenzhe Duan1, Wenwen Liu2
1Department of Respiratory Medicine, The Second Hospital, Dalian Medical University, No. 467 Zhongshan Road, Dalian, 116023, China.
Glucose-regulating protein 78 (GRP78) is crucial in lung cancer progression and treatment. This review details GRP78's role in tumor development, stress response, and its potential as a biomarker and therapeutic target.
Area of Science:
- Molecular biology
- Oncology
- Cellular stress response
Background:
- Glucose-regulating protein 78 (GRP78) is an endoplasmic reticulum chaperone involved in protein folding and stress signaling.
- GRP78 is frequently upregulated in tumors, acting as a sensor for the tumor microenvironment and mediating cancer cell stress responses.
- Elevated GRP78 levels correlate with lung cancer progression and poor prognosis.
Purpose of the Study:
- To comprehensively review the functions and mechanisms of GRP78 in lung cancer pathology.
- To elucidate GRP78's role in tumorigenesis, apoptosis, autophagy, progression, and drug resistance.
- To discuss GRP78's potential as a prognostic biomarker and therapeutic target for lung cancer.
Main Methods:
- Literature review of GRP78 functions in lung cancer.
- Analysis of GRP78's involvement in key pathological processes.
- Discussion of GRP78's implications for diagnosis and treatment.
Main Results:
- GRP78 plays a significant role in sensing and adapting to the tumor microenvironment.
- GRP78 influences critical cancer hallmarks including cell survival, proliferation, and resistance to therapy.
- Evidence supports GRP78's association with disease progression and treatment outcomes in lung cancer.
Conclusions:
- GRP78 is integral to the pathological processes of lung cancer.
- Targeting GRP78 presents a promising strategy for novel lung cancer therapies.
- GRP78 holds potential as a valuable biomarker for lung cancer prognosis and assessment.
More Related Videos
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
07:39The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018